January 6-7, 2022 webconference

The Longwood Healthcare Leaders meeting, centered on Stanford/San Francisco via webconference on Thursday, January 6 - Friday, January 7, 2022 prior to the JP Morgan Healthcare Conference, brings together leading biopharma CEOs, heads of R&D, top academic researchers, and healthcare investors for an off-the-record forum focused on accelerating the translation of discoveries into medicines to help patients.

Speakers include Stanford University President Marc Tessier-Lavigne, Stanford School of Medicine Dean Lloyd Minor, Daiichi Sankyo Executive Chair, head of R&D, and President Glenn Gormley, AbbVie Chief Strategy Officer Henry Gosebruch, SeaGen CEO Clay Siegall, Nestle Health Science CEO Greg Behar, Vir Bio CMO Phil Pang, Alladapt CEO Ashley Dombkowski, Xontogeny CEO Chris Garabedian, Takeda Neuroscience head Beth Shafer, Genocea CEO Chip Clark, among others. Substantial donations enabled by these meetings benefit Life Science Cares, The Boston Foundation, BSO, Harvard Medical School, MIT, and other charities.

LONGWOOD HEALTHCARE LEADERS WINTER MEETING | DRAFT AGENDA | JANUARY 6-7, 2022

- all times Pacific Standard –

 

7:00 – 7:30 | LONGWOOD FUND INTRODUCTION

 

7:30 – 8:00 | NEWCO TO ESTABLISHED: BUILDING A BIOTECH

 

8:00 – 8:30 | R&D COLLABORATION

 

8:30 – 8:50 | FIRESIDE CHAT
Marc Tessier-Lavigne, President, Stanford; Lloyd Minor, Dean, Stanford Medicine

 

8:50 – 9:20 | BULDING GLOBAL BIOPHARMAS

 

9:20 – 9:50 | IPO MARKET FORCAST

 

9:50 – 10:20 | SOURCING AND IDENTIFYING NOVEL TECHNOLOGY

 

10:20 – 10:40 | FIRESIDE CHAT

 

10:40 – 11:10 | INNOVATION IN CELL THERAPY

 

11:10 – 11:40 | CULTIVATING AN ECOSYSTEM OF PARTNERS 

 

11:40 – 12:00 | FIRESIDE CHAT

 

12:00 – 12:30 | HOW M&A SPURS INNOVATION 

 

12:30 – 1:00 | SCIENTIFIC INNOVATION: LAUNCHING COMPANIES FROM ACADEMIA

 

1:00 – 1:30 | ADVANCING PLATFORM TECHNOLOGIES

 

1:30 – 1:50 | FIRESIDE CHAT

 

1:50 – 2:20 | EXPEDITING RESEARCH FOR TREATMENTS AND CURES

 

2:20 – 2:50 | ALTERNATIVE SOURCES OF FINANCING

 

2:50 – 3:20 | ACCELERATING DRUG DEVELOPMENT

 

3:20 – 3:40 | FIRESIDE CHAT

 

3:40 – 4:10 | MAKING A BIG IMPACT WITH LIMITED RESOURCES

 

4:10 – 4:40 | DRUG APPROVALS: INSIGHTS, OUTLOOK, AND COMMITMENT TO PATIENTS

 

4:40 – 5:10 | BUSINESS DEVELOPMENT: SELECTING THE RIGHT PARTNER

 

5:10 – 5:40 | MAKING SMART INVESTMENTS

 

5:40 – 6:00 | LONGWOOD FUND SUMMARY

 

 

FRIDAY, JANUARY 7, 2022

 

7:00 – 7:30 | LONGWOOD FUND INTRODUCTION

 

7:30 – 8:00 | HARNESSING BIOMEDICAL INNOVATION

 

8:00 – 8:20 | MODERATED KEYNOTE

 

8:20 – 8:50 | HEALTH SYSTEMS IN A NEW ERA

 

8:50 – 9:20 | BIG BIOPHARMA R&D

 

9:20 – 9:50 | SPOTLIGHT: STANFORD INNOVATION

 

9:50 – 10:20 | THE NEXT WAVE OF TARGETED THERAPIES

 

10:20 – 10:40 | FIRESIDE CHAT

 

10:40 – 11:10 | DESIGNING THE DEAL 

 

11:10 – 11:40 | BIOPHARMA REGULATORY & INDUSTRY TRENDS

 

11:40 – 12:10 | GETTING TO DRUG APPROVAL

 

12:10 – 12:30 | FIRESIDE CHAT

 

12:30 – 1:00 | FINANCING INNOVATION

 

1:00 – 1:30 | CLINICAL TRIAL DIVERSITY

 

1:30 – 2:00 | NOVEL THERAPEUTIC MODALITIES

 

2:00 – 2:20 | FIRESIDE CHAT

 

2:20 – 2:50 | R&D TRANSFORMATION

 

2:50 – 3:20 | INNOVATION HUBS

 

3:20 – 3:40 | FIRESIDE CHAT

 

3:40 – 4:10 | NOVEL APPROACHES TO DUG DISCOVERY

 

4:10 – 4:40 | THE NEXT WAVE OF FINANCINGS: IPOS, REVERSE MERGERS, SPACS

 

4:40 – 5:00 | FIRESIDE CHAT

 

5:00 – 5:30 | EXTERNAL INNOVATION

 

5:30 – 6:00 | INNOVATIVE PARTNERSHIPS

 

6:00 – 6:30 | LONGWOOD FUND SUMMARY